Call for Abstract

3rd World Congress on Pharmacology, will be organized around the theme “(New) Drug Discovery: Multiple Trails Towards a Broadway”

Pharmacology 2016 is comprised of 16 tracks and 64 sessions designed to offer comprehensive sessions that address current issues in Pharmacology 2016.

Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.

Register now for the conference by choosing an appropriate package suitable to you.

Pharmacology  is the study of how substances interact with living organisms to produce a change in function. It deals with the research, discovery, and characterization of chemicals which show biological effects and the illumination of cellular and organism function in relation to these chemicals. If substances have medicinal properties, they are considered pharmaceuticals. The Pharmacology encompasses mechanisms of drug action, drug composition and properties, interactions, toxicology, therapies, medical applications, and antipathogenic capabilities.

  • Track 1-1Scope
  • Track 1-2Medicine development and safety testing
  • Track 1-3Drug legislation and safety

Neuropharmacology is the study of how drugs affect cellular function in the nervous system, and the neural mechanisms through which they influence behavior. There are two main branches of neuropharmacology: behavioral and molecular. Neuropharmacology is the study of how drugs affect cellular function in the nervous system, and the neural mechanisms through which they influence behavior. There are two main branches of neuropharmacology: behavioral and molecular. It is dealt with the interactions of neurotransmitters, neuropeptides, neurohormones, neuromodulators, enzymes, second messengers, co-transporters, ion channels, and receptor proteins in the central and peripheral nervous systems.

The global revenue for single use technology reached $1.4 billion and $1.7 billion in 2013 and 2014, respectively. This market is expected to grow at a compound annual growth rate (CAGR) of 11.7% to nearly $3.0 billion for the period 2014-2019.

  • Track 2-1Neurogenesis and repair
  • Track 2-2Neurochemical interactions
  • Track 2-3Molecular neuropharmacology
  • Track 2-4Behavioral neuropharmacology
  • Track 2-5Alzheimer’s and Parkinson’s Disease

 Pharmacokinetic and pharmacodynamic parameters become important because of the association between host drug concentrations, microorganism eradication, and resistance.Since long scientific advances allowed scientists to come together with the study of physiological effects with biological effects.

The Pharmaceutical industry's long successful strategy of placing big bets on a few molecules, promoting them heavily and turning them into blockbusters worked well for many years, but its R&D productivity has now plummeted and the environment’s changing.

  • Track 3-1Pharmacokinetic aspects
  • Track 3-2Drug interactions and pharmacological compatibilities
  • Track 3-3Receptor theory for drug effects
  • Track 3-4Clinical efficacy and safety evaluation
  • Track 3-5Novel options for the pharmacological treatment of chronic diseases
  • Track 3-6Drug biotransformation reactions

Psychopharmacology is the learning of the effects of medication on the psyche (psychology), observing changed behaviors and how molecular events are manifest in a measurable behavioral form. Neuropharmacology is the study of the effects of medication on central and peripheral nervous system performance.

The global market for drug discovery technologies reached nearly $39.5 billion and $46.5 billion in 2013 and 2014, respectively. This market is expected to grow at a compound annual growth rate (CAGR) of 11.3% to nearly $79.5 billion for the period 2014-2019.

  • Track 4-1Neuro Immune pharmacology and its associated diseases
  • Track 4-2Psychotherapy and innovative psychopharmacological approaches
  • Track 4-3Dose response relation in psychiatric medications
  • Track 4-4Effect of androgenic anabolic steroids on psychosis

Pharmacology of vascular endothelium deals with alterations of endothelial cells and the vasculature play a central role in the pathogenesis of a broad spectrum of the most dreadful of human diseases, as endothelial cells have the key function of participating in the maintenance of patent and functional capillaries.

This market is expected to increase from nearly $17.1 billion in 2015 to $23 billion by 2020, with a compound annual growth rate (CAGR) of 6.1% from 2015 to 2020.

  • Track 5-1Pharmacology of drugs affecting vascular tone and blood pressure
  • Track 5-2Role of drugs in coronary circulation
  • Track 5-3Drugs and the electrical conduction of the heart
  • Track 5-4Drugs and the failing heart
  • Track 5-5Pharmacology of the Vascular endothelium

Ethnopharmacology is the branch of pharmacology that deals with the exchange of information and understandings about people's use of plants, fungi, animals, microorganisms and minerals and their biological and pharmacological effects based on the principles established through international conventions.

The pharmaceutical market been increasingly more affected through laws and regulations but has shown continuous growth as the diagnosis and understanding of diseases and condition has evolved and improved. BCC Research report’s cover the latest pharmaceutical market and provide in-depth market analysis, forecasts, trends, patent analysis, and profiles of major players within the markets.

  • Track 6-1Integrative Pharmacological Investigations
  • Track 6-2Ethnopharmacological perspectives from traditional to modern pharmaceuticals.
  • Track 6-3Natural products chemistry in drug discovery
  • Track 6-4Chemistry and structural elucidation
  • Track 6-5Natural and synthetic derivatives in pharmacological studies

Pharmacogenetics refers to how variation in one single gene influences the response to a single drug and Pharmacogenomicsrefers to how all of the genes (the genome) can influence responses to drugs. The general feature of these diverse lesions is that two nucleotides on opposite strands are joined covalently. Mutagenicity and carcinogenicity are clearly correlated.Understanding the specificity of mutagens in bacteria has led to the direct implication of certain environmental mutagens in the causation of human cancers

The Pharmaceutical industry's long successful strategy of placing big bets on a few molecules, promoting them heavily and turning them into blockbusters worked well for many years, but its R&D productivity has now plummeted and the environment’s changing. Regulators are becoming more cautious about approving truly innovative medicines.

  • Track 7-1Molecular epidemiology and its biomarkers
  • Track 7-2Molecular pathological epidemiology
  • Track 7-3Pharmacovigilance and post marketing surveillance
  • Track 7-4Adverse event reporting system

Toxicology is the study of the undesirable effects of chemicals on living organisms. It is the study of symptoms, mechanisms, treatments and detection of poisoning, especially the poisoning of people.

The global market for selected healthcare-acquired infection (HAI) treatments was valued at nearly $15.2 billion in 2014. This market is expected to increase from nearly $17.1 billion in 2015 to $23 billion by 2020, with a compound annual growth rate (CAGR) of 6.1% from 2015 to 2020.

  • Track 8-1 Dose response complexities
  • Track 8-2Computational toxicology
  • Track 8-3Clinical toxinology
  • Track 8-4Toxins and toxinology

Recent advances in DNA repair are DNA interstrand cross-links (ICLs) are lesions caused by a variety of endogenous metabolites, ecological exposures, and cancer chemotherapeutic agents that have two reactive groups.

An overview of biopharmaceutical single-use technologies, which aid the manufacturing process in overcoming such complex issues as sterilization and critical manufacturing parameters. Analyses of global market trends, with data from 2013 and 2014, and projections of CAGRs through 2019.

  • Track 9-1Molecular epidemiology and its biomarkers
  • Track 9-2Molecular pathological epidemiology
  • Track 9-3Pharmacovigilance and post marketing surveillance
  • Track 9-4Adverse event reporting system

Reverse pharmacology includes drug screening deals with reverse pharmacology and forward pharmacology are two approaches to drug discovery. Target based drug discovery is the process through which potential new medicines are identified.

The global market for drug discovery technologies reached nearly $39.5 billion and $46.5 billion in 2013 and 2014, respectively. This market is expected to grow at a compound annual growth rate (CAGR) of 11.3% to nearly $79.5 billion for the period 2014-2019.

  • Track 10-1Reverse pharmacology
  • Track 10-2Target based drug discovery
  • Track 10-3Screening of chemical libraries and its pharmacology
  • Track 10-4Methods To determine biological targeting
  • Track 10-5Classical pharmacology

Liposomes and nanoparticles: Nanoscale drug delivery systems using liposomes and nanoparticles are rising technologies for the rational delivery of chemotherapeutic drugs in the treatment various ailments. Nanoparticles present possible dangers, both medically and environmentally.

The pharmaceutical industry is directly impacted by the research conducted with prescription drugs, vaccines, and OTC drugs being manufactured based on findings from the study of life sciences. Clinical trials are conducted to ensure that products being developed are tested on how well they work on individuals affected by the diseases or conditions they are created to treat.

  • Track 11-1Liposomes and nanoparticles: nanosized vehicles for drug delivery
  • Track 11-2Epigenetic mechanisms of importance for drug treatment
  • Track 11-3Pharmacometrics
  • Track 11-4Techniques: The application of accelerator mass spectrometry to pharmacology and toxicology

Ocular Pharmacology deals with basic and clinical research about biopharmaceuticals that have the potential to prevent, treat, and/or diagnose ocular diseases and disorders and its associated treatments.

The global market for selected healthcare-acquired infection (HAI) treatments was valued at nearly $15.2 billion in 2014. This market is expected to increase from nearly $17.1 billion in 2015 to $23 billion by 2020, with a compound annual growth rate (CAGR) of 6.1% from 2015 to 2020.

  • Track 12-1Glaucoma and its advanced and intregrated treatments
  • Track 12-2Ocular pharmacotherapy/clinical trials
  • Track 12-3Ocular drug delivery and biotransformation
  • Track 12-4Ocular ischemia and blood flow
  • Track 12-5Ocular inflammatory and immune disorders

Biochemical pharmacology is based on principles of drug action. Biochemical pharmacology uses the methods of biochemistry, biophysics, molecular biology, structural biology, cell biology, and cell physiology to define the mechanisms of drug action and how drugs influence the organism by studies on intact animals, organs, cells, subcellular compartments and individual protein molecules.

An overview of biopharmaceutical single-use technologies, which aid the manufacturing process in overcoming such complex issues as sterilization and critical manufacturing parameters. Analyses of global market trends, with data from 2013 and 2014, and projections of CAGRs through 2019.

  • Track 13-1Use of tissue and animal models of human pathophysiology and toxicology
  • Track 13-2Mechanism of drug action, safety and efficacy
  • Track 13-3Mechanisms of drug absorption across membranes
  • Track 13-4Drug biotransformation reactions

Development of medication is a vital concern to medicine. The metabolic stability and the reactivity of a library of candidate drug compounds have to be assessed for drug metabolism and toxicological studies. Many methods of pharmacological tests have been proposed for quantitative predictions in drug metabolism.

The pharmaceutical market been increasingly more affected through laws and regulations but has shown continuous growth as the diagnosis and understanding of diseases and condition has evolved and improved. BCC Research report’s cover the latest pharmaceutical market and provide in-depth market analysis, forecasts, trends, patent analysis, and profiles of major players within the markets. Comprehensive analysis of clinical studies for biopharmaceuticals, prevention and treatment of certain cancers, coagulants and non-coagulants are all within the range of pharmaceutical markets covered in BCC Research reports. Drug devices, instrumentation and inhibitors are some of the many other areas covered.

  • Track 14-1Advances in Stress Test
  • Track 14-2Advances in Nuclear Stress Test
  • Track 14-3Advances in Pharmacological Testing
  • Track 14-4Safety Pharmacology

Pharmacology for nurses is one of the most important elements in nursing education. It is the field is science that is related to management of drugs as per the disease profile of the patient. This i sa special track designed in Pharmacology 2016 Conference.

The pharmaceutical industry is directly impacted by the research conducted with prescription drugs, vaccines, and OTC drugs being manufactured based on findings from the study of life sciences. Clinical trials are conducted to ensure that products being developed are tested on how well they work on individuals affected by the diseases or conditions they are created to treat.

  • Track 15-1Nursing Implications
  • Track 15-2Management of Congestive Heart Failure

World Congress on Pharmacology is a productive conclave focussing in collaboration and communication among the Pharma Professional Business Entrepreneurs and  Pharma Indusrtrial Persons. Meetings fall apart thanks to sloppy agendas in making their Annual planning about developing their Business. Here's how some of the world's top execs participate in this congress and share their views and ideas.